| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |